Abstract
The recent progress on controlled-release drug delivery systems with cyclodextrins as functional groups and their applications in nanomedicine are reviewed. As one of the most famous supramolecular host candidates, cyclodextrins with small guest molecules are extensively employed in controlled-release drug delivery systems in nanomedicine fields. The host-guest interactions between cyclodextrins and the guest molecules can be triggered by various stimulations, including temperature, light, pH, etc. In this review, we will focus on the cyclodextrinbased controlled-release systems mainly triggered by light. The comparison between photoresponsive and other controlled-release drug delivery systems is also discussed.
Keywords: Photochemistry, cyclodextrin, stimuli-responsive, drug delivery, controlled-release, polymer, mesoporous silica, hydrogel.
Graphical Abstract
Current Organic Chemistry
Title:Photoinduced Controlled-Release Drug Delivery Systems for Applications in Nanomedicine
Volume: 20 Issue: 17
Author(s): Zhao Yuan and Lu Zhang
Affiliation:
Keywords: Photochemistry, cyclodextrin, stimuli-responsive, drug delivery, controlled-release, polymer, mesoporous silica, hydrogel.
Abstract: The recent progress on controlled-release drug delivery systems with cyclodextrins as functional groups and their applications in nanomedicine are reviewed. As one of the most famous supramolecular host candidates, cyclodextrins with small guest molecules are extensively employed in controlled-release drug delivery systems in nanomedicine fields. The host-guest interactions between cyclodextrins and the guest molecules can be triggered by various stimulations, including temperature, light, pH, etc. In this review, we will focus on the cyclodextrinbased controlled-release systems mainly triggered by light. The comparison between photoresponsive and other controlled-release drug delivery systems is also discussed.
Export Options
About this article
Cite this article as:
Yuan Zhao and Zhang Lu, Photoinduced Controlled-Release Drug Delivery Systems for Applications in Nanomedicine, Current Organic Chemistry 2016; 20 (17) . https://dx.doi.org/10.2174/1385272820666160112001944
DOI https://dx.doi.org/10.2174/1385272820666160112001944 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Thematic Issue: New Advances of Drug Design in Cancer Disease Part II)
Current Bioactive Compounds Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy
Current Cancer Drug Targets DNA Repair Helicases as Targets for Anti-Cancer Therapy
Current Medicinal Chemistry Specific and Sensitive RP-HPLC Method Development and Validation for the Determination of Aripiprazole: Application in Preformulation Screening of Nanoemulsion
Current Nanomedicine Cancer Chemoprevention by Natural Carotenoids as an Efficient Strategy
Anti-Cancer Agents in Medicinal Chemistry Targeting the Type I Insulin-Like Growth Factor System for Breast Cancer Therapy
Current Drug Targets Down with the Erythropoietin. Long Live the Erythropoietin !
Current Drug Targets Bispecific Antibody (bsAb) Construct Formats and their Application in Cancer Therapy
Protein & Peptide Letters β2-AR-HIF-1α: A Novel Regulatory Axis for Stress-Induced Pancreatic Tumor Growth and Angiogenesis
Current Molecular Medicine Targeting the ERK Pathway: Novel Therapeutics for Thyroid Cancer
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Contribution of Poly(Amino Acids) to Advances in Pharmaceutical Biotechnology
Current Pharmaceutical Biotechnology CB 1954: From the Walker Tumor to NQO2 and VDEPT
Current Pharmaceutical Design PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials
Current Drug Targets Synthesis and Biological Activity of Pyrazolo[4,3-c]heterocyclic Derivatives: A Mini Review
Mini-Reviews in Organic Chemistry A Decrease in the Cellular Phosphodiester to Phosphomonoester Lipid Ratio is Characteristic of HIV-1 Infection
Current HIV Research Biology of PPARγ in Cancer: A Critical Review on Existing Lacunae
Current Molecular Medicine Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer
Current Pharmaceutical Design Anti-Egfr Therapy in Colorectal Cancer: How to Choose The Right Patient
Current Drug Targets Simultaneous determination of Curcumin (Cur) and Thymoquinone (THQ) in lipid based self-nanoemulsifying systems and its application to the commercial product using UHPLC-UV-Vis spectrophotometer
Current Pharmaceutical Analysis Aflibercept: A Novel VEGF Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Tumors
Mini-Reviews in Medicinal Chemistry